Stocktoria
Century Therapeutics, Inc. IPSC
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-17
Century Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 4,980,526 | $12.2M | 5.69% |
| MILLENNIUM MANAGEMENT LLC | 4,194,981 | $10.3M | 4.79% |
| BlackRock Finance, Inc. | 2,895,613 | $7.4M | 3.31% |
| TWO SIGMA INVESTMENTS, LP | 2,699,013 | $6.6M | 3.08% |
| RENAISSANCE TECHNOLOGIES LLC | 1,257,700 | $3.1M | 1.44% |
| CITADEL ADVISORS LLC | 351,770 | $861,837 | 0.4% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.